Pharma

Jan 7 2018

To be niche players in neurology oncology: Eisai Pharma #drug #companies

#eisai pharma # While most Japanese drugmakers have been cautious post the Daiichi Sankyo’s crisis in Ranbaxy, Eisai Pharma is the only Japanese pharma company that continues to place its bet on the Indian pharma space. The company has consolidated its manufacturing and commercial operations in India and is adopting a multipronged growth strategy. The company which has been operating a Greenfield manufacturing facility in Vizag and is looking to grow its business in India. The plant currently caters entirely to the Japanese market. However Eisai wants to convert its India facility into a global sourcing hub that will export …

Nov 26 2017

Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #pharmaceuticals #industry

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …

Nov 23 2017

To be niche players in neurology oncology: Eisai Pharma #pharma #r&d

#eisai pharma # While most Japanese drugmakers have been cautious post the Daiichi Sankyo’s crisis in Ranbaxy, Eisai Pharma is the only Japanese pharma company that continues to place its bet on the Indian pharma space. The company has consolidated its manufacturing and commercial operations in India and is adopting a multipronged growth strategy. The company which has been operating a Greenfield manufacturing facility in Vizag and is looking to grow its business in India. The plant currently caters entirely to the Japanese market. However Eisai wants to convert its India facility into a global sourcing hub that will export …

Nov 14 2017

To be niche players in neurology oncology: Eisai Pharma #biotechnology #careers

#eisai pharma # While most Japanese drugmakers have been cautious post the Daiichi Sankyo’s crisis in Ranbaxy, Eisai Pharma is the only Japanese pharma company that continues to place its bet on the Indian pharma space. The company has consolidated its manufacturing and commercial operations in India and is adopting a multipronged growth strategy. The company which has been operating a Greenfield manufacturing facility in Vizag and is looking to grow its business in India. The plant currently caters entirely to the Japanese market. However Eisai wants to convert its India facility into a global sourcing hub that will export …

Nov 9 2017

Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #real #pharma

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …

Aug 30 2017

Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #pharma #medical

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …

Aug 19 2017

Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #leading #pharmaceutical #companies

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …

Aug 15 2017

To be niche players in neurology oncology: Eisai Pharma #pharma #trust

#eisai pharma # While most Japanese drugmakers have been cautious post the Daiichi Sankyo’s crisis in Ranbaxy, Eisai Pharma is the only Japanese pharma company that continues to place its bet on the Indian pharma space. The company has consolidated its manufacturing and commercial operations in India and is adopting a multipronged growth strategy. The company which has been operating a Greenfield manufacturing facility in Vizag and is looking to grow its business in India. The plant currently caters entirely to the Japanese market. However Eisai wants to convert its India facility into a global sourcing hub that will export …

Aug 1 2017

To be niche players in neurology oncology: Eisai Pharma #pharma #design

#eisai pharma # While most Japanese drugmakers have been cautious post the Daiichi Sankyo’s crisis in Ranbaxy, Eisai Pharma is the only Japanese pharma company that continues to place its bet on the Indian pharma space. The company has consolidated its manufacturing and commercial operations in India and is adopting a multipronged growth strategy. The company which has been operating a Greenfield manufacturing facility in Vizag and is looking to grow its business in India. The plant currently caters entirely to the Japanese market. However Eisai wants to convert its India facility into a global sourcing hub that will export …

Jul 25 2017

Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #big #pharma #etf

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …